Advances in Clinical Chemistry

Publishes cutting-edge reviews in the field of clinical chemistry that include the expertise of international contributors

Gregory S. Makowski (Edited by)

9780323988377, Elsevier Science

Hardback, published 20 January 2022

298 pages
22.9 x 15.1 x 2.3 cm, 0.45 kg

Advances in Clinical Chemistry, Volume 106, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, with this new release focusing on Advances in ADAMTS biomarkers, Advances in fibrosis biomarkers in nonalcoholic fatty liver disease, Metabolomics of Peripheral Artery Disease, Molecular and cellular functions of long non-coding RNAS in prostate and breast cancer, Myostatin: Basic Biology to Clinical Application, and Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.

1. Advances in ADAMTS biomarkers
Rahel Schnellmann
2. Advances in fibrosis biomarkers in nonalcoholic fatty liver disease
Stefano Ciardullo and Gianluca Perseghin
3. Metabolomics of peripheral artery disease
Ahmed Ismaeel, Ramon Lavado, and Panagiotis Koutakis
4. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer
Yuan-Shan Zhu and Jifeng Zhu
5. Myostatin: Basic biology to clinical application
Pasquale Esposito, Daniela Picciotto, Yuri Battaglia, Francesca Costigliolo, Francesca Viazzi, and Daniela Verzola
6. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer
Muhammad T. Abdel Ghafar and Nema A. Soliman

Subject Areas: Biochemistry [PSB]